Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1987 | 09-1987 | 06-1987 | 12-1986 | 12-1985 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 13,744 | 3,806 | 5,318 | 14,717 | 17,389 |
| TOTAL | $13,744 | $3,806 | $5,318 | $14,717 | $17,389 |
| Non-Current Assets | |||||
| PPE Net | 311,106 | 299,371 | 292,000 | 280,255 | 266,519 |
| Investments And Advances | 3,327 | 3,370 | 0 | 3,824 | 2,983 |
| Other Non-Current Assets | 7,741 | 5,074 | 4,774 | 4,859 | 5,332 |
| TOTAL | $322,174 | $307,815 | $296,774 | $288,938 | $274,834 |
| Total Assets | $335,918 | $311,621 | $302,092 | $303,655 | $292,223 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 36,108 | 48,907 | 37,118 | 29,783 | 20,242 |
| Accounts payable and accrued liabilities | 22,768 | 15,537 | 12,761 | 24,193 | 29,221 |
| Accrued Expenses | 3,543 | 2,166 | 1,995 | 3,015 | 3,352 |
| TOTAL | $78,578 | $94,742 | $84,207 | $88,841 | $86,080 |
| Non-Current Liabilities | |||||
| TOTAL | $48,173 | $47,721 | $46,513 | $45,719 | $43,496 |
| Total Liabilities | $126,751 | $142,463 | $130,720 | $134,560 | $129,576 |
| Shareholders' Equity | |||||
| Common Shares | 112,721 | 110,109 | 111,532 | 107,629 | 102,143 |
| TOTAL | $112,721 | $110,109 | $111,532 | $107,629 | $102,143 |
| Total Liabilities And Equity | $239,472 | $252,572 | $242,252 | $242,189 | $231,719 |